Home›Stock Screener›Dr. Lal Path Labs›Quarterly Results

Dr. Lal Path Labs Quarterly Results

Latest Quarter Net Profit
₹132 Cr
QMar 2026
Quarterly Results

Dr. Lal Path Labs quarterly results. In Mar 2026, Dr. Lal Path Labs (LALPATHLAB) reported revenue ₹727 Cr and net profit ₹132 Cr — revenue +15.8% YoY. For annual financials, live price and key ratios, visit Dr. Lal Path Labs stock price NSE.

LALPATHLAB Quarterly Results — Revenue, Profit & EPS Highlights

Dr. Lal Path Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check LALPATHLAB market cap trends to track the company's total market size over time.

  • Revenue of ₹727 Cr in Mar 2026 (-12.4% vs Jun 2026, +15.8% vs Mar 2025)
  • Net Profit of ₹132 Cr in Mar 2026 (-22.8% vs Jun 2026, -15.4% vs Mar 2025)
  • EBITDA of ₹211 Cr in Mar 2026 (-24.4% vs Jun 2026)
  • Operating Margin of 27.0% in Mar 2026 (-4.0pp vs Jun 2026)
  • Earnings Per Share of ₹7.86 in Mar 2026 (-22.6% vs Jun 2026)

Dr. Lal Path Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS

LALPATHLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 727 830 755 628 698 -12.4% 15.8%
Net Profit (₹ Cr) 132 171 152 156 134 - -
EBITDA (₹ Cr) 211 279 249 195 220 - -
EPS (₹) 7.86 10.15 18.05 18.57 15.88 - -
Operating Margin (%) 27.0% 31.0% 31.0% 28.0% 29.0% - -

LALPATHLAB Share Price Trend — 1-Year Movement Across Quarterly Results

Dr. Lal Path Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review LALPATHLAB P/E comparison to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 18.2%
EBITDA Margin 29.0%
Operating Margin 27.0%
ROE (Annual) 20.8%

Balance Sheet Highlights

Total Assets ₹3,146 Cr
Total Equity ₹2,541 Cr
Current Assets ₹ Cr
Current Liabilities ₹154 Cr

Cash Flow Analysis

Operating Cash Flow ₹636 Cr
Investing Cash Flow ₹-422 Cr
Financing Cash Flow ₹-264 Cr
Net Cash Flow ₹-50 Cr

Current Market Data

Current Price ₹1843.70
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 628
Sept 2025 755
Jun 2026 830
Mar 2026 727

Net Profit Trend (₹ Cr)

Mar 2025 156
Sept 2025 152
Jun 2026 171
Mar 2026 132

Operating Margin Trend (%)

Mar 2025 28.0%
Sept 2025 31.0%
Jun 2026 31.0%
Mar 2026 27.0%

LALPATHLAB vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap

Dr. Lal Path Labs latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Apollo Hospitals
Mar 2026 		₹109,276.34 Cr 7604.5 6,660 551 -6.3% - 8.3% 206.5
Max Healthcare Inst…
Mar 2026 		₹80,784.75 Cr 817.0 2,191 342 -9.0% - 15.6% 232.1
Fortis Healthcare
Mar 2026 		₹55,700.81 Cr 726.7 2,375 271 -7.7% - 11.4% 206.4
Aster DM Healthcare
Mar 2026 		₹42,146.56 Cr 654.7 1,219 154 -0.6% +18.1% 12.6% 240.7
Narayana Hrudayalaya
Mar 2026 		₹35,577.17 Cr 1693.2 2,623 224 -3.5% - 8.5% 153.6
Sector Quarterly Performance Comparison
Healthcare Services sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores